1
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
Condition(s):NeuroblastomaLast Updated:July 20, 2022Recruiting
Neuroblastoma: 670 Clinical Trials, Page 1 of 67
Hide Studies Not Open or Pending
2
Neuroblastoma Precision Trial
Condition(s):NeuroblastomaLast Updated:February 17, 2022Active, not recruiting
3
Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma
Condition(s):NeuroblastomaLast Updated:August 31, 2021Not yet recruiting
4
Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL
Condition(s):NeuroblastomaLast Updated:June 9, 2016Completed
5
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma
Condition(s):NeuroblastomaLast Updated:August 9, 2022Recruiting
6
Investigating the Microbiome and Volatile Organic Compound Profile of Children With Neuroblastoma
Condition(s):Microbial Colonization; Neuroblastoma; Children, OnlyLast Updated:February 25, 2020Recruiting
7
Nutritional Status in Neuroblastoma in Sao Paolo, Brazil
Condition(s):NeuroblastomaLast Updated:July 30, 2018Recruiting
8
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients
Condition(s):NeuroblastomaLast Updated:August 5, 2019Terminated
9
Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
Condition(s):NeuroblastomaLast Updated:March 29, 2022Active, not recruiting
10
Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells
Condition(s):Neuroblastoma RecurrentLast Updated:March 30, 2018Unknown status